Tumoral angiogenesis: Models, targets and inhibition;Angiogenèse tumorale: modèles, cibles et inhibition

Journal de la Societe de Biologie

Volumn 203, Issue 2, 2009, Pages 167-170

  Bikfalvi, Andreas ^a  

^a INSERM   (France)

Author keywords

Chicken chorio allantoic membrane; Tumoral angiogenesis

Indexed keywords

ANGIOGENESIS INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANGIOGENESIS; ANIMAL; CELL HYPOXIA; CHICK EMBRYO; CHORIOALLANTOIS; DRUG EFFECT; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; UNFOLDED PROTEIN RESPONSE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL HYPOXIA; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; UNFOLDED PROTEIN RESPONSE;

EID: 77952299148     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio/2009020     Document Type: Article

References (10)

1. Bikfalvi A., Angiogenesis: health and disease. Ann Oncol 2006, 17 Suppl 10, 65-70.
2. Borges J., Tegtmeier F.T., Padron N.T., Mueller M.C., Lang E.M., Stark G.B., Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Eng, 2003, 9, 441-450.
3. Djonov V., Schmid M., Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res, 2000, 86, 286-292.
4. Drogat B., Auguste P., Nguyen D.T., Bouchecareilh M., Pineau R., Nalbantoglu J., Kaufman R.J., Chevet E., Bikfalvi A., Moenner M., IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res, 2007, 67, 6700-6707.
5. Hagedorn M., Balke M., Schmidt A., Bloch W., Kurz H., Javerzat S., Rousseau B., Wilting J., Bikfalvi A., VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis. Dev Dyn, 2004, 230, 23-33.
6. Hagedorn M., Javerzat J., Gilges D., Meyre A., de Lafarge B., Eichmann A., Bikfalvi A., Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci U S A, 2005, 102, 1643-1648.
7. Nguyen M., Shing Y., Folkman J., Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane.Microvasc Res, 1994, 47, 31-40.
8. North S., Moenner M., Bikfalvi A., Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. Cancer Lett, 2005, 218, 1-14.
9. Saidi A., Javerzat S., Bellahc̀ene A., De Vos J., Bello L., Castronovo V., Deprez M., Loiseau H., Bikfalvi A., Hagedorn M., Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int J Cancer, 2008, 122, 2187-2198.
10. Staton C.A., Lewis C., Bicknell R., Angiogenesis Assays: A Critical Appraisal of Current Techniques. Ed Wiley, John & Sons, Incorporated, February 2007, ISBN-13: 9780470016008, 400pp.